Tiny dissolving implant tested to fight glaucoma
NCT ID NCT06964061
Summary
This early-stage study is testing a small, dissolving implant placed in the eye to lower internal eye pressure in adults with open-angle glaucoma or ocular hypertension. About 12 participants will receive a single implant and be followed for about a year to see how well it works, how safe it is, and how long it takes to dissolve. The goal is to see if this one-time implant can provide long-term control of eye pressure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPEN ANGLE GLAUCOMA (OAG) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cataract & Eye Surgery Centre
RECRUITINGDoncaster, Victoria, 3109, Australia
-
Cerulea Pty Ltd
RECRUITINGEast Melbourne, Victoria, 3002, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Melbourne Eye Specialists
RECRUITINGMelbourne, Victoria, 3000, Australia
Conditions
Explore the condition pages connected to this study.